Analyst Consensus ?
ConsensusBuy16 ratings
Bullish1381.3%
Neutral212.5%
Bearish16.2%
FN2 Earnings Intelligence
West Pharmaceutical Services, Inc. analyst ratings
West Pharmaceutical Services, Inc. (WST) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$403.64Previous close
$295Low
$372Average
$447High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 13, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 7, 2026 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Sep 22, 2026 |
| UBS | Buy | Buy | Maintain | Sep 9, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 3, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 27, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Jul 2, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jun 2, 2026 |
| B of A Securities | Buy | Buy | Maintain | Dec 13, 2024 |
| Jefferies | Buy | Hold | Upgrade | Feb 7, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Dec 14, 2022 |
| Bank of America | Underperform | Neutral | Downgrade | Dec 12, 2019 |
| William Blair | Outperform | Outperform | Maintain | Apr 23, 2019 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 24, 2018 |
| Wells Fargo | Outperform | Outperform | Maintain | Oct 27, 2017 |
| Janney Capital | Buy | Buy | Maintain | Jan 8, 2016 |
Named analyst price targets
Upside is calculated against the persisted previous close $403.64. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Luke Sergott | $440 | $372.64 | +9.0% | Oct 7, 2026 |
| Morgan Stanley | Kallum Titchmarsh | $400 | $361.73 | -0.9% | Sep 22, 2026 |
| UBS | Analyst unavailable | $415 | $338.06 | +2.8% | Sep 9, 2026 |
| Evercore ISI | Analyst unavailable | $425 | $333.12 | +5.3% | Jul 27, 2026 |
| BNP Paribas | Analyst unavailable | $447 | $353.71 | +10.7% | Jul 13, 2026 |
| Morgan Stanley | Analyst unavailable | $365 | $353.68 | -9.6% | Jul 9, 2026 |
| Evercore ISI | Daniel Markowitz | $410 | $359.27 | +1.6% | Jul 6, 2026 |
| KeyBanc | Analyst unavailable | $390 | $365 | -3.4% | Jul 2, 2026 |
| Barclays | Luke Sergott | $400 | $319.75 | -0.9% | Jun 9, 2026 |
| Morgan Stanley | Analyst unavailable | $315 | $306.39 | -22.0% | Apr 27, 2026 |
| Barclays | Analyst unavailable | $310 | $306.16 | -23.2% | Apr 27, 2026 |
| UBS | Dan Leonard | $340 | $246.6 | -15.8% | Feb 13, 2026 |
| Deutsche Bank | Analyst unavailable | $315 | $247.49 | -22.0% | Feb 13, 2026 |
| Barclays | Luke Sergott | $265 | $243.61 | -34.3% | Feb 13, 2026 |
| Jefferies | David Windley | $295 | $249.97 | -26.9% | Feb 10, 2026 |
| Evercore ISI | Daniel Markowitz | $320 | $237.88 | -20.7% | Feb 3, 2026 |
| Morgan Stanley | Analyst unavailable | $285 | $274.14 | -29.4% | Dec 1, 2025 |
| Barclays | Analyst unavailable | $325 | $293.62 | -19.5% | Oct 27, 2025 |
| UBS | Dan Leonard | $355 | $307.25 | -12.1% | Oct 24, 2025 |
| Deutsche Bank | Justin Bowers | $345 | $304.74 | -14.5% | Oct 24, 2025 |
| Evercore ISI | Daniel Markowitz | $390 | $309.28 | -3.4% | Oct 23, 2025 |
| Evercore ISI | Analyst unavailable | $350 | $268.07 | -13.3% | Oct 7, 2025 |
| Barclays | Analyst unavailable | $275 | $271.42 | -31.9% | Oct 2, 2025 |
| Redburn Partners | Jamie Clark | $311 | $257.53 | -23.0% | Sep 15, 2025 |
| Barclays | Luke Sergott | $245 | $222.68 | -39.3% | Jun 24, 2025 |
| Jefferies | David Windley | $393 | $287.85 | -2.6% | Nov 19, 2024 |
| Jefferies | David Windley | $536 | $413 | +32.8% | Feb 7, 2024 |
| Deutsche Bank | Analyst unavailable | $250 | $251.9 | -38.1% | Dec 14, 2022 |
| UBS | Analyst unavailable | $250 | $222.84 | -38.1% | Nov 30, 2022 |
Track every rating change on WST the moment it posts. Free to start.
Start freeGet the WST recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.